Staar Surgical reported a net loss of $2.1 million, or $0.05 per share, in 2017 compared with a net loss of $12.1 million, or $0.30 per share, in 2016, according to a press release.
Net sales increased 10% to $90.6 million for the year compared with $82.4 million in 2016. The increase was attributed to ICL revenue and unit growth and strong injector part sales, the release said. IOL sales decreased 12%.
In 2017’s fourth quarter, the company reported a net loss of $0.1 million compared with a $0.2 million (Read more...)
Uncategorized